£

We're here for you if you want to talk

0808 2080 888

[email protected]

Myelodysplastic syndromes (MDS) are a group of conditions where your bone marrow does not work properly and makes faulty blood cells. MDS is a type of blood cancer.

Funding information

The following pharmaceutical companies and charitable organisations helped fund this information, but had no influence over it: Abbvie, AstraZeneca, Incyte, Jazz Pharmaceuticals, Kyowa Kirin, Roche, Sobi UK, The Garfield Weston Foundation, The Steel Charitable Trust and The Grace Trust.

Find out how we work with the pharmaceutical industry.

This information about MDS is accredited with the PIF TICK, the UK's only quality mark for trusted health information.

Last full review June 2023. Next full review due June 2026. We may make factual updates to the information between reviews.

We would like to thank Consultant Haematologists Dr Daniel Wiseman and Dr Pramila Krishnamurthy for checking the medical accuracy of our MDS information. Thanks also to Ally, Emma, Kal, Peter, Simon and Tony for supporting this project and sharing their experience of living with MDS.